Glenmede Trust CO Na Biogen Inc. Transaction History

Glenmede Trust CO Na

$19.6 Billion
Q2 2024

A detailed history of Glenmede Trust CO Na transactions in Biogen Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 10,718 shares of BIIB stock, worth $1.86 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,718

Previous 12,429 13.77%

Holding current value

$1.86 Million

Previous $2.68 Million 7.31%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $325,979 - $405,027	-1,711 Reduced 13.77%	10,718 $2.48 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $232,161 - $293,142	-1,095 Reduced 8.1%	12,429 $2.68 Million
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $3.28 Million - $3.95 Million	-14,740 Reduced 52.15%	13,524 $3.5 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $14.8 Million - $16.7 Million	-58,328 Reduced 67.36%	28,264 $7.26 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $30,002 - $34,668	-109 Reduced 0.13%	86,592 $24.7 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $660,128 - $752,190	-2,573 Reduced 2.88%	86,701 $24.1 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $3.18 Million - $3.87 Million	12,607 Added 16.44%	89,274 $24.7 Million
Q3 2022 Nov 16, 2022	SELL	$194.69 - $268.46 $6.38 Million - $8.8 Million	-32,762 Reduced 29.94%	76,667 $20.5 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $1.62 Million - $1.92 Million	-8,615 Reduced 7.3%	109,429 $22.3 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $1.27 Million - $1.6 Million	-6,573 Reduced 5.27%	118,044 $24.9 Million
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $4.89 Million - $6.29 Million	-21,842 Reduced 14.91%	124,617 $29.9 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $108,951 - $142,084	385 Added 0.26%	146,459 $41.4 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $13.3 Million - $21.2 Million	-51,178 Reduced 25.95%	146,074 $50.6 Million
Q1 2021 May 18, 2021	SELL	$242.95 - $284.63 $48 Million - $56.2 Million	-197,559 Reduced 50.04%	197,252 $55.2 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $2.55 Million - $3.84 Million	-10,788 Reduced 2.66%	394,811 $96.7 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $10.8 Million - $12.4 Million	-40,684 Reduced 9.12%	405,599 $115 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $22.6 Million - $29.9 Million	-87,239 Reduced 16.35%	446,283 $119 Million
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $21 Million - $29.1 Million	-95,565 Reduced 15.19%	533,522 $158 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $1.39 Million - $1.56 Million	-6,392 Reduced 1.01%	629,087 $146 Million
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $42.5 Million - $46.9 Million	194,018 Added 43.95%	635,479 $149 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $1.14 Million - $1.79 Million	5,282 Added 1.21%	441,461 $104 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $7.68 Million - $9.73 Million	27,590 Added 6.75%	436,179 $131 Million
Q3 2018 Nov 15, 2018	SELL	$293.51 - $383.83 $3.84 Million - $5.03 Million	-13,095 Reduced 3.11%	408,589 $144 Million
Q2 2018 Aug 15, 2018	BUY	$257.52 - $306.91 $24.4 Million - $29.1 Million	94,748 Added 28.98%	421,684 $122 Million
Q4 2017 Feb 15, 2018	SELL	$307.64 - $344.58 $3.97 Million - $4.45 Million	-12,917 Reduced 3.8%	326,936 $104 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $95.5 Million - $112 Million	339,853	339,853 $0

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Biogen Inc. Transaction History